Table 4: Base-case cost-effectiveness analysis comparison of ACS with labor to usual care.

GA weeksStrategyCost
($)
IC
($)
Efficacy
(Utiles)
IE
(Utiles)
C/E
($/Utile)
ICER
($/QALY)
Interpretation

34No ACS12.8 K155.81182.24Dominant
ACS19.9 K 7.1 K155.923 0.112127.55 62,888.25

35No ACS12.6 K155.79280.59Dominant
ACS19.8 K 7.2 K155.904 0.112126.76 64,425.67

36No ACS12.5 K155.77480.33Dominant
ACS19.7 K 7.2 K155.885 0.112126.66 64,793.71

ACS: antenatal corticosteroids; GA: gestational age; IC: incremental cost; IE: incremental efficacy; QALY: quality adjusted life year.